Overview

Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The hypothesis is that treating hay fever patients who had daytime sleepiness and slowed thinking because of the hay fever will improve when treated with an effective anti-hay fever medication, an intranasal steroid, that is will have less daytime sleepiness and demonstrate better thinking.
Phase:
Phase 4
Details
Lead Sponsor:
Western Sky Medical Research
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone
Xhance